PT3458478T - Anti pd-1 and anti-lag3 antibodies for cancer treatment - Google Patents

Anti pd-1 and anti-lag3 antibodies for cancer treatment

Info

Publication number
PT3458478T
PT3458478T PT177268620T PT17726862T PT3458478T PT 3458478 T PT3458478 T PT 3458478T PT 177268620 T PT177268620 T PT 177268620T PT 17726862 T PT17726862 T PT 17726862T PT 3458478 T PT3458478 T PT 3458478T
Authority
PT
Portugal
Prior art keywords
cancer treatment
lag3 antibodies
lag3
antibodies
cancer
Prior art date
Application number
PT177268620T
Other languages
Portuguese (pt)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT3458478T publication Critical patent/PT3458478T/en

Links

PT177268620T 2016-05-18 2017-05-17 Anti pd-1 and anti-lag3 antibodies for cancer treatment PT3458478T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2016170174 2016-05-18

Publications (1)

Publication Number Publication Date
PT3458478T true PT3458478T (en) 2021-02-26

Family

ID=74717038

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177268620T PT3458478T (en) 2016-05-18 2017-05-17 Anti pd-1 and anti-lag3 antibodies for cancer treatment

Country Status (2)

Country Link
HR (1) HRP20210412T1 (en)
PT (1) PT3458478T (en)

Also Published As

Publication number Publication date
HRP20210412T1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
IL262892A (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
IL267803A (en) Methods of treating cancer with anti-tim-3 antibodies
HK1251474A1 (en) Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
HK1252272A1 (en) Methods of treating cancer using anti-ox40 antibodies
IL263178A (en) Pd-1 / pd-l1 inhibitors for cancer treatment
IL265541B2 (en) Bispecific antibodies and compositions comprising thereof for treating cancer
ZA201904316B (en) Methods of treating cancer with anti-pd-1 antibodies
HK1247848A1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
HK1251862A1 (en) Methods and compositons for treating cancer
IL264674B1 (en) Anti-siglec-7 antibodies for the treatment of cancer
EP3426777A4 (en) Combination vectors and methods for treating cancer
IL260474B (en) Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment
EP3177292A4 (en) Compounds and methods for treating cancer
EP3589659A4 (en) Compounds and methods for treating cancer
EP3119426A4 (en) Methods and materials for treating cancer
EP3119427A4 (en) Methods and materials for treating cancer
EP3697767A4 (en) Compounds and methods for treating cancer
ZA201802618B (en) Anti-cd43 antibody and use thereof for cancer treatment
EP3568145A4 (en) Materials and methods for treating cancer
EP3303289A4 (en) Compounds and methods for treating cancer
EP3273970A4 (en) Methods and materials for treating cancer
GB2571036B (en) Aglycosylated antibody Fc region for treating cancer
PT3458478T (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
GB201609402D0 (en) Materials and methods for treating cancer
GB201720089D0 (en) Means and methods for treating cancer